Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclosporine + omeprazole versus omeprazole alone in new-onset type 1 diabetes
2015-000105-39Phase 2Terminated
- Sponsor
- Perle Bioscience
- Start
- Jun 2015
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in diabetes mellitus type 1 (T1D) comparing Cyclosporine + omeprazole with Omeprazole alone (2 arms). Primary endpoint: Insulin independence at 24 weeks. Started Jun 2015; status: terminated.
02
Drugs
cyclosporineomeprazole
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2015-000105-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-000105-39.